Recombinant Rat Interleukin-1 Receptor Antagonist Protein
![mRNA synthesis](/media/diy/images/page/figure1-mrna.png)
mRNA synthesis
In vitro transcription of capped mRNA with modified nucleotides and Poly(A) tail
![Tyramine Signal Amplification (TSA)](/media/diy/images/page/figure2-01.png)
Tyramide Signal Amplification (TSA)
TSA (Tyramide Signal Amplification), used for signal amplification of ISH, IHC and IC etc.
![screening library](/media/diy/images/page/figure3-01.png)
Phos Binding Reagent Acrylamide
Separation of phosphorylated and non-phosphorylated proteins without phospho-specific antibody
![Cell Counting Kit-8 (CCK-8)](/media/diy/images/page/CCK-8.jpg)
Cell Counting Kit-8 (CCK-8)
A convenient and sensitive way for cell proliferation assay and cytotoxicity assay
![SYBR Safe DNA Gel Stain](/media/diy/images/page/SYBR Safe DNA Gel Stain.png)
SYBR Safe DNA Gel Stain
Safe and sensitive stain for visualization of DNA or RNA in agarose or acrylamide gels.
![Inhibitor Cocktails](/media/diy/images/page/Inhibitor Cocktails.jpg)
Inhibitor Cocktails
Protect the integrity of proteins from multiple proteases and phosphatases for different applications.
IL-1RA 最初被称为 IL-1 抑制剂,由 IL1RN 基因编码,是白细胞介素 1 细胞因子家族的成员。IL-1RA由多种类型的细胞分泌,包括免疫细胞、上皮细胞和脂肪细胞。IL-RA 具有通过与受体 IL1R1 结合并阻止其与共受体 IL1RAP 结合进行信号传导来抑制白细胞介素-1 活性的功能。IL-1RA还用于治疗类风湿性关节炎,这是一种自身免疫性疾病,IL-1在其中起关键作用。大鼠 IL-1RA 是一条含有 152 个氨基酸的非糖基化多肽链,已被证明在体外和体内阻断 IL-1 诱导的炎症反应。大鼠IL-1RA与小鼠和人IL-1RA具有89%和73%的a.a.序列同源性。
Reference
1. Dinarello CA. 1994. FASEB J. 8:1314-25
2. Patterson D, Jones C, Hart I, et al. 1993. Genomics. 15:173-6
3. Steinkasserer A, Spurr NK, Cox S, et al. 1992. Genomics. 13:654-7
4. Perrier S, Darakhshan F, Hajduch E. 2006. FEBS Lett. 580:6289-94
5. Gabay C, Porter B, Fantuzzi G, et al. 1997. J Immunol. 159:5905-13.
Gene ID | 60582 |
Accession # | P25086 |
Alternate Names | IL-1RN, IRAP, IL1 Inhibitor |
Source | Escherichia coli. |
M.Wt | Approximately 17.4 kDa, a single non-glycosylated polypeptide chain containing 152 amino acids. |
AA Sequence | HPAGKRPCKM QAFRIWDTNQ KTFYLRNNQL IAGYLQGPNT KLEEKIDMVP IDFRNVFLGI HGGKLCLSCV KSGDDTKLQL EEVNITDLNK NKEEDKRFTF IRSETGPTTS FESLACPGWF LCTTLEADHP VSLTNTPKEP CTVTKFYFQE DQ |
Appearance | Sterile Filtered White lyophilized (freeze-dried) powder. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. - 12 months from date of receipt, -20 to -70 °C as supplied. - 1 month, 2 to 8 °C under sterile conditions after reconstitution. - 3 months, -20 to -70 °C under sterile conditions after reconstitution. |
Formulation | Lyophilized from a 0.2 μm filtered concentrated solution in PBS, pH 7.4. |
Reconstitution | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions. |
Biological Activity | Fully biologically active when compared to standard. The ED50 as determined by inhibiting IL-1α-dependent proliferation of murine D10S cells is less than 150 ng/ml, corresponding to a specific activity of > 6.7 × 103 IU/mg in the presence of 50 pg/ml rRtIL-1α. |
Shipping Condition | Gel pack. |
Handling | Centrifuge the vial prior to opening. |
Usage | For Research Use Only! Not to be used in humans. |
质量控制和DataSheet
- 批次:
-
纯度 > 96 % by SDS-PAGE and HPLC analyses.
- Datasheet
Endotoxin: Less than 1 EU/μg of rRtIL-1RA as determined by LAL method.